Specifically designed for the Dimension clinical chemistry system, this LPBN assay utilizes a heterogeneous immunoassay module for precise in vitro diagnostic testing.
It quantitatively determines the levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) in human serum or plasma, offering critical insights for clinicians.
NT-proBNP measurements are crucial for diagnosing and assessing the severity of congestive heart failure (CHF), aiding healthcare professionals in making informed decisions.
The assay is also valuable for the risk stratification of patients suspected of cardiovascular conditions, providing a reliable tool for patient management.
